# Anti-Obesity Activity of Giant Centella asiatica Lava Seawater Extract (GCA-LS-90) Through Regulation of Adipocyte Differentiation and Lipid Metabolism In Vitro

**Authors:** Sekyung Lee, Daebang Seo, Chan Yoo, Hae Dun Kim, Hyung Joo Suh, Hyun Jung Lee

PMC · DOI: 10.3390/ijms27052287 · International Journal of Molecular Sciences · 2026-02-28

## TL;DR

This study shows that a seawater extract from Giant Centella asiatica reduces fat cell formation and boosts GLP-1, a hormone linked to appetite control, in lab tests.

## Contribution

The study introduces GCA-LS-90 as a novel extract with anti-obesity potential through its regulation of adipogenesis and GLP-1 secretion.

## Key findings

- GCA-LS-90 reduced lipid accumulation in 3T3-L1 cells by 24.3% at 200 µg/mL.
- The extract modulated key adipogenic and lipogenic genes and proteins.
- GCA-LS-90 increased GLP-1 secretion in STC-1 cells by 53.5 pmol/L at 90 µg/mL.

## Abstract

Obesity is well-known as a major risk factor for metabolic disorders, and natural compounds are being explored as alternatives to conventional therapies. While Centella asiatica is well known for its medicinal and dietary benefits, the biological activities of Giant Centella asiatica (GCA), especially when extracted with mineral-rich lava seawater, remain poorly characterized. This study aimed to evaluate the anti-adipogenic and lipid-metabolism-regulating effects of a novel GCA extract (GCA-LS-90) and its ability to stimulate GLP-1 secretion in vitro. GCA-LS-90 significantly inhibited lipid accumulation in 3T3-L1 adipocytes by up to 24.3% at 200 µg/mL (p < 0.001). It downregulated adipogenic transcription factors (C/EBPβ, C/EBPα, PPARγ) and lipogenic regulators (SREBP1c, FAS, G6PD, ME), while upregulating KLF2 (all p < 0.001). Western blotting confirmed reduced SREBP1c and SREBP2 protein expression, increased phosphorylation of AMPKα/ACC, and enhanced HSL activity (p < 0.05–0.001). In STC-1 cells, GCA-LS-90 increased GLP-1 secretion (53.5 pmol/L at 90 µg/mL vs. 41.3 pmol/L in control, p < 0.001). The major compounds, 3,5- and 4,5-di-O-caffeoylquinic acids, reproduced these effects. In conclusion, GCA-LS-90 modulated adipogenesis-, lipid-metabolism-, and GLP-1 secretion-related pathways in vitro, suggesting its potential as a functional ingredient for obesity management. Further in vivo studies are needed to confirm efficacy and translational relevance.

## Linked entities

- **Genes:** CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051], CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 78968], FAS (Fas cell surface death receptor) [NCBI Gene 355], G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539], MMP12 (matrix metallopeptidase 12) [NCBI Gene 4321], KLF2 (KLF transcription factor 2) [NCBI Gene 10365], SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721], ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31], LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991]
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, KLF2 (KLF transcription factor 2) [NCBI Gene 10365] {aka LKLF}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721] {aka SREBP-2, SREBP2, bHLHd2}, LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991] {aka AOMS4, FPLD6, HSL, LHS, REH}
- **Diseases:** Obesity (MESH:D009765), metabolic disorders (MESH:D008659)
- **Chemicals:** Lipid (MESH:D008055), 3,5- and 4,5-di-O-caffeoylquinic acids (-)
- **Species:** Centella asiatica (Asiatic pennywort, species) [taxon 48106]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984701/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984701/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984701/full.md

---
Source: https://tomesphere.com/paper/PMC12984701